Keynote Speaker Suneil Hosmane joins Louise Campbell and Roger Green to form the coverage team for the 4th Global NASH Congress. In this conversation, Jörn Schattenberg joins them to review drug-related topics covered at the Congress. This conversation discusses issues ranging from modes of action that attack fructose metabolism to the importance of hearing regulators at meetings like this one. Listen to get a feel for what commercial, financial and R & D actors can hear about by attending the event on April 28 and 29.

TOPICS: 89bio, FDA, FGF-21, Nordic Biosciences, 4th Global NASH Congress, Global Engage, Pfizer, ketohexakinase inhibition, fructose metabolism, EMEA, de-escalating therapies

Surfing The NASH Tsunami is brought to you by HEP Dynamics
#HEPdynamics #SurfingNASH #podcast